Cryoviva (Thailand) Ltd. is the first stem cell bank to be recognized by Frost & Sullivan, earning the prestigious Stem Cell Company of the Year title for three consecutive years from 2015 to 2017. Under the leadership of Chief Executive Officer Chiranya Prachaseri, the company has achieved remarkable milestones, standing as the only company in Thailand with continued accreditation for over a decade.
Cryoviva’s commitment to excellence has been further solidified through accolades like the Stem Cell Company Growth Excellence Leadership Award in 2018 and an expanding presence in over 20 countries, including Thailand, Singapore, Vietnam, Myanmar, Cambodia, and Laos. Catering primarily to families looking to preserve stem cells for future health benefits, Cryoviva has built a reputation as a trusted leader in the Southeast Asian stem cell industry.
A Visionary Leader with Global Insights
Chiranya Prachaseri attributes much of Cryoviva’s success to her global exposure, having been educated in both Asia and the United States while gaining professional experience across multiple countries. This international perspective has allowed her to integrate the best practices from both the East and West, creating an ideal foundation for Cryoviva’s operations.
One of the biggest challenges in the stem cell banking industry, according to Chiranya, is ensuring uncompromised quality at every stage of the process, from collection and storage to eventual transplantation. “When the need arises for the use of stem cells, every process—from collection to storage—is crucial. We take no chances, ensuring the highest standards to guarantee the best possible outcomes for our clients.”
Her leadership, coupled with the foresight of Cryoviva’s investors, has enabled the company to maintain the highest standards, including international accreditation from AABB (formerly the American Association of Blood Banks, USA). The company is also actively investing in new technologies for stem cell therapies and regenerative medicine, keeping Cryoviva at the forefront of innovation.
A Passion for Philanthropy and Social Impact
Inspired by her parents—both successful business figures and dedicated philanthropists—Chiranya has embedded corporate social responsibility (CSR) into Cryoviva’s core values. Her personal experience as the mother of twin daughters, one of whom has Down syndrome, led her to establish the Down Syndrome Support Group of Thailand, extending her dedication to social causes beyond the corporate realm.
Cryoviva’s CSR initiatives reflect this ethos, including the Cryoviva Fund for Stem Cell Transplant Patients, a charity walk-run event called “Run for a New Life,” and financial grants for underprivileged patients requiring stem cell transplants.
Leadership with Purpose and Compassion
Recognized as one of Asia’s Most Inspiring Executives at this year’s ACES Awards, Chiranya believes that a great leader must be hands-on. “A good leader doesn’t sit in an ivory tower but rolls up their sleeves and works alongside their team.”
She emphasizes a people-first approach, ensuring not only professional growth but also personal well-being among her employees. “When you treat your team like family while maintaining fair leadership, you create a winning culture.”
Describing her leadership style as that of a coach, Chiranya fosters creativity and innovation, believing that empowering employees leads to both business success and effective succession planning.
Banking on Empathy, Innovation, and Leadership
In an industry as personal as stem cell banking, leadership must extend beyond strategic decisions—it must embody empathy, hope, and compassion. Chiranya Prachaseri exemplifies this, seamlessly balancing her role as a business strategist and a leader with a human touch.
Shanggari Balakrishnan, CEO of MORS Group, perfectly encapsulates Chiranya’s impact:
“Cryoviva’s Chiranya Prachaseri demonstrates these attributes in a most stellar way, while also being able to wear the hat of a business strategist and charismatic leader.”
